Abstract

The JCVI held a second extraordinary meeting on vaccines for SARS-CoV-2 (COVID-19), looking at:

  • Review of epidemiological data
  • COVID-19 sero-epidemiology
  • Delivery of candidate COVID-19 vaccines
  • Influenza programme – considering COVID-19
  • Risk factors for serious disease and mortality
  • Vaccine platforms
  • Vaccine development update
  • Immune responses to infection
Agenda & Minutes Europe United Kingdom